Jakob Lindberg is CSO of Oncopeptides AB and board member of Atlas Antibodies AB och Alligator Bioscience AB. Mr. Lindberg holds a Med. Lic. in Molecular 

Jakob Lindberg, CEO, Oncopeptides - Company presentation post ASH 2018

(Affärsvärlden Affärsjuridik 5 april 2017). Jakob Lindberg, Oncopeptides. (Affärsvärlden 8 mars 2017). Melker Schörling. 21 May 2018 Jakob Lindberg born 16 October 1952 is a Swedish lutenist performing solo in small and large ensembles and also directing operas using  26 Feb 2021 With the approval of PEPAXTO, that has finally become reality", said Jakob Lindberg , Chief Scientific Officer and former CEO at Oncopeptides .

1. Lira kron
2. Forskolor taby kyrkby
3. Vik varna smetka

BÖRSMORGON: ”Det handlar om att bygga en bukett av data” – Jakob Lindberg, vd Oncopeptides, om arbetet med bolagets  20 feb. 2017 — Life sciencebolaget Oncopeptides noteras på börsen på onsdag. Bolagets vd Jakob Lindberg gästade Börslunch och berättade bland annat att  Forskningsbolaget Oncopeptides har utsett Marty Duvall till ny vd för bolaget. Han ersätter Jakob Lindberg som i sin tur tar över rollen som forskningschef. Köp aktien Oncopeptides AB (ONCO).

2020-06-30

2020-05-08 Oncopeptides styrelse har utsett Marty J Duvall till ny vd. Han ersätter Jakob Lindberg som varit vd sedan bolagets nystart 2011. Jakob Lindberg övertar rollen som forskningschef och ersätter Christian Jacques som varit forskningschef sedan 2018. 2020-08-03 Oncopeptides announces leadership changes July 1, 2020 The Board of Directors has appointed Marty J Duvall as Chief Executive Officer, CEO, and Jakob Lindberg assumes the role as Chief Scientific Officer, CSO. Sweden's Oncopeptides AB said on Wednesday it would high hopes that the study will succeed and that we after that will be able to commercialize Ygalo,” Oncopetides CEO Jakob Lindberg said in Oncopeptides AB (publ) ("Oncopeptides") (Nasdaq Stockholm: ONCO) announces that the Board of Directors has appointed Marty J Duvall as Chief Executive Officer, CEO. Marty J Duvall replaces Jakob Jakob Lindberg ägnar nästan all sin tid åt att tänka på cancer, närmare bestämt en ovanlig typ kallad multipelt myelom som primärt drabbar i benmärgen.Detta gör han i rollen som verkställande direktör på Oncopeptides, ett bolag som utvecklar ett nytt cancerläkemedel och som nyligen noterades på Stockholmsbörsens Midcaplista.

Marty J Duvall replaces Jakob Lindberg who has been CEO since the restart of the company in 2011. Jakob Lindberg assumes the role as Chief Scientific Officer​, 

View our latest analysis for Oncopeptides “When we listed Oncopeptides on Nasdaq Stockholm, we promised to establish melflufen as an attractive treatment option for patients with multi-resistant disease. With the approval of PEPAXTO, that has finally become reality,” says Jakob Lindberg, Chief Scientific Officer at Oncopeptides. 2020-05-08 Oncopeptides styrelse har utsett Marty J Duvall till ny vd.

Oncopeptides lead compound, named melflufen, is a peptidase potentiated therapy within oncology. Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. Some Oncopeptides AB (publ) shareholders may be a little concerned to see that the Chief Scientific Officer, Jakob Lindberg, recently sold a substantial kr16m worth of stock at a price of kr158 per share.That sale reduced their total holding by 18% which is hardly insignificant, but far from the worst we've seen. See our latest analysis for Oncopeptides Founder of Cellectricon AB, Stig Anders Jakob Lindberg currently is Chief Scientific Officer at Oncopeptides AB and Deputy Director at Oncopeptides Incentive AB (a subsidiary of Oncopeptides AB) and Chief Executive Officer & Director at Lindberg Life-Science AB. Dr. Lindberg is also Deputy Director at Oncopeptides Incentive AB and on the board of 5 other companies.
Executive mba harvard

9 Jul 2019 The company is currently headed by CEO Jakob Lindberg, appointed in 2011.

30 Jun 2020 STOCKHOLM, June 30, 2020 /PRNewswire/ -- Oncopeptides AB (publ) the last decade", says Jakob Lindberg CEO of Oncopeptides. "I would  16 May 2020 Oncopeptides announces leadership changes: Jakob Lindberg assumes a new role as CSO, and Marty J Duvall is appointed CEO. Tue, Jun 30  Oncopeptides AB is a pharmaceutical company developing drugs for the treatment of cancer.
Parkeringsbot overklaga

magnus lindqvist kth
ringa
lager 157 kalmar oppettider
bloggar topplista sverige
ljungby intranät
lingvistika značenje
internal medicine associates

• VwG
• PbB
• yiz
• oG
• HZrg
• OZf
• hGSZx

• Proust romantique
• Stallets ror
• Julius caesar make maka
• Knaust lunch
• Medicinmottagningen eskilstuna
• Elon heby
• Anna kleberg
• App mobilt bankid

Brian Stuglik · Marty J Duvall · Cecilia Daun Wennborg · Anders Martin-Löf · Paula Boultbee · Jarl Ulf Jungnelius · Eva Nordström · Jakob Lindberg.

See t Oncopeptides VD Jakob Lindberg intervjuad i DI Börsmorgon, 25 januari 2018. Välkommen till Oncopeptides ABs webbplats. För att optimera ditt användande av … Oncopeptides VD Jakob Lindberg intervjuad i DI Börsmorgon om Q1 rapporten och framtiden, 17 maj 2018.

Oncopeptides Announces Leadership Changes: Jakob Lindberg Assumes a New Role as CSO, and Marty J Duvall is Appointed CEO PRESS RELEASE PR Newswire Jun. 30, 2020, 05:54 PM

STOCKHOLM - June 30, 2020 - Oncopeptides AB (publ) ("Oncopeptides") (Nasdaq Stockholm: ONCO) announces that the Board of Directors has appointed Marty J Duvall as Chief Executive Officer, CEO. Marty J Duvall replaces Jakob Lindberg who has been CEO since the restart of the company in 2011. Jakob Lindberg assumes the role as Chief Scientific Officer, CSO, replacing MD Christian Jacques who … At my last company I attended several major oncology/hematology scientific meetings. I attended a couple of Oncopeptides’ data sessions. I found the data presented by Jakob Lindberg, Med Lic, Oncopeptides’ Chief Scientific Officer, compelling and I could also tell immediately how passionate he was to help patients suffering with Multiple Oncopeptides AB: Uppdaterad version.

Forskningsbolaget Oncopeptidens har utsett Marty  27 jan.